Latest filing published 19 May 2025 for Ultragenyx Pharmaceutical Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Amrit Ray: trading record in brief
This profile gathers the share dealings of Amrit Ray across 2 companies, led by Ultragenyx Pharmaceutical Inc. and Fortrea Holdings Inc. Over a trading history stretching from 19 April 2022 to 15 May 2025, the count stands at 7 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 19 May 2025, reports a share grant in Ultragenyx Pharmaceutical Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Amrit Ray
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,740 shares0Common StockSEC:0000950170-25-074661:0
- 7,282 shares0Common StockSEC:0001127602-25-014739:0
- 6,354 shares0Common StockSEC:0001127602-24-020748:0
- 5,345 shares0Common StockSEC:0000950170-24-075486:0
- 3,860 shares0Common StockSEC:0001209191-23-035692:0
- 3,300 shares0Common StockSEC:0001209191-22-039564:0
- 5,120 shares0Common StockSEC:0001209191-22-025279:0
7 of 7 declarations
